(Q42993897)

English

Interferon-alpha plus ribavirin in chronic hepatitis C resistant to previous interferon-alpha course: results of a randomized multicenter trial.

scientific article published in May 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365803%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Interferon-alpha plus ribavirin in chronic hepatitis C resistant to previous interferon-alpha course: results of a randomized multicenter trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365803%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

multicenter clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

Pietro Andreone

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365803%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Carmela Cursaro

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365803%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

A Gramenzi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365803%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

G Sbolli

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365803%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

S Fiorino

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365803%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

L Di Giammarino

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365803%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

R Miniero

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365803%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

A D'Errico

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365803%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

G Gasbarrini

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365803%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

M Bernardi

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365803%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 May 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365803%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Journal of Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365803%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365803%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365803%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

788-793

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365803%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980130-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology of Hepatitis C in the West

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980130-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical outcomes after transfusion-associated hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980130-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The treatment of chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980130-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980130-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Ribavirin treatment for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980130-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980130-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980130-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980130-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of hepatitis C viruses with a nonconserved sequence of the 5' untranslated region

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980130-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Avoiding false positives with PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980130-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation and comparison of different hepatitis C virus genotyping and serotyping assays

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980130-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980130-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Ribavirin and interferon-alpha combination therapy vs interferon-alpha alone in the retreatment of chronic hepatitis C: a randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980130-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980130-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Retreatment with interferon-alpha of chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980130-5

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose interferon-alpha 2b for re-treatment of nonresponders or relapsing patients with chronic hepatitis C. A controlled randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980130-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C viral RNA titers in serum prior to, during, and after oral treatment with ribavirin for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980130-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in hepatitis C virus antigen in liver with antiviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980130-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of ribavirin on intrahepatic and extrahepatic expression of hepatitis C virus in interferon nonresponsive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980130-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Modulation of hepatitis C virus quasispecies heterogeneity by interferon-alpha and ribavirin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980130-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined interferon-alpha 2, rimantadine hydrochloride, and ribavirin inhibition of influenza virus replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980130-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980130-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of sustained response, relapse and no response in patients with chronic hepatitis C treated with interferon-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980130-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Increase in hepatic iron stores following prolonged therapy with ribavirin in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980130-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-8278(99)80130-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365803%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365803%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42993897&oldid=2083158072"